Skip to content
Research Article Open access CC BY 4.0

A Note on the Current Status of the Trans-ungual Delivery of Poorly Soluble Drugs at a Glance: Formulation Perspective

Srinivas Bhairy, Alfiha Momin, Mugdha Pednekar, Devendra Madan, Ashraf Shaikh, Rahul Bankar, Subrahmanyam Pitchika

Asian Journal of Research in Infectious Diseases · pp. 1–21 · Published 21 Feb 2023

10.9734/ajrid/2023/v12i3244

Abstract

The Trans ungual drug delivery (TUDD) system involves the delivery of drugs through the hard keratinized nail plate. Topical treatment is ideal for treating nail diseases because it has localized effects, resulting in fewer systemic side effects and perhaps better adherence. Conventional formulations have failed to promote nail adhesion and medication absorption due to the nail's highly keratinized hydrophilic nature, which obstructs drug absorption. Systemic therapy has several side effects and a high rate of recurrence, whereas surgery is painful and invasive. As a result, there is a definite need to design an efficient TUDD system that allows antifungals to penetrate the nail and reach the infection site at a sufficient concentration and for a longer period of action to eliminate the infection. The system also avoids the oral toxicity of drugs. Several techniques, including physical, chemical, and mechanical, are employed to increase medication penetration over the nail plate. To increase nail adherence, therapeutic action, and bioavailability, several innovative formulation techniques are being researched, including the use of penetration enhancers in traditional dosage forms (gel, solution), novel dosage forms such as films, nail lacquer, and nanotechnology.

Trans ungual drug delivery human nail anti-fungal permeation novel formulations nanotechnology bioavailability

Cited by 2

A recent review on transungual drug delivery system

Simran Kaur, Mohit Kumar, Amit Bhatia · Journal of Dispersion Science and Technology · 2024

Therapeutic treatment strategies for the management of onychomycosis: a patent perspective

Snigdha Chakraborty, Sanshita, Inderbir Singh · Expert Opinion on Therapeutic Patents · 2023

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

2

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.